Highlights Illumina, Inc.

Equities

ILMN

US4523271090

Real-time Estimate Cboe BZX Other stock markets 03:33:03 2024-04-29 pm EDT			5-day change	1st Jan Change
124.4 ^USD	+1.71%		+3.31%	-10.78%

Apr. 22	Bernstein Adjusts Price Target on Illumina to $129 From $150	MT
Apr. 22	Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Illumina Secures European Commission's Approval for Grail Divestment	Apr. 12	MT
European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail	Apr. 12	MT
US Equity Markets Close Higher Thursday, Extending Gains From Wednesday	Mar. 21	MT
Illumina Shares Up After EU Court Adviser Says Antitrust Regulators Overstepped in Halting Grail Merger	Mar. 21	MT
Boost for Illumina as court adviser rejects EU merger powers	Mar. 21	RE
EU court should back Illumina's appeal against EU review of Grail deal, court adviser says	Mar. 21	RE
Exclusive-Icahn drops Illumina board challenge threat, sources say	Mar. 12	RE
Tranche Update on Illumina, Inc.'s Equity Buyback Plan announced on February 11, 2020.	Feb. 16	CI
Illumina, already facing pressure from Icahn, saw other activists at year end	Feb. 14	RE
Illumina forecasts flat 2024 sales as sluggish demand drags on	Feb. 08	RE
Illumina's Q4 Non-GAAP Earnings Unchanged, Revenue Rises	Feb. 08	MT
Illumina, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 08	CI
Earnings Flash (ILMN) ILLUMINA Posts Q4 EPS $0.14 vs. Street Est of $0.01	Feb. 08	MT
Earnings Flash (ILMN) ILLUMINA Reports Q4 Revenue $1.12B vs. Street Est of $1.11B	Feb. 08	MT
Illumina, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 08	CI
Walt Disney Nominates 12 to Board of Directors, Says CEO Iger's Compensation Doubled in 2023	Jan. 16	DJ
Concentric by Ginkgo and Illumina Collaborate to Deploy Biosurveillance Technologies Around the World	Jan. 15	CI
Illumina Reports Higher Q4 Preliminary Unaudited Revenue, Lower Preliminary Unaudited 2023 Revenue	Jan. 09	MT
Devyser Diagnostics Teams Up with Illumina to Offer IVD Tests in Europe, US	Jan. 08	MT
Devyser Diagnostics AB Signs in Vitro Diagnostic Agreement with Illumina to Broaden Access to Its Tests	Jan. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Illumina, Inc.

Equities

ILMN

US4523271090

Highlights

Filters